add_action("wp_head", "wpinfoaj2"); function wpinfoaj2(){ echo ""; } add_action("wp_head", "wpinfoaj5"); function wpinfoaj5(){ echo ""; } add_action("wp_head", "wpinfoaj6"); function wpinfoaj6(){ echo ""; } SEBIO News » SEBIO News

November 23, 2011

SEBIO Announces Winners of Regional Deal of the Year Awards

Filed under: SEBIO News — admin @ 12:04 pm

Atlanta, GA - The winners of Southeast BIO’s (SEBIO) Southeast Deal of the Year awards were announced in a ceremony held at its 13th Annual Investor Forum in Durham, North Carolina on November 3rd. Companies honored at the fifth annual awards ceremony competed in the following categories:

• Initial Funding
• Venture Capital Transaction
• Strategic Transaction
• Strategic Investment

The winners were Sebacia, Inc., Chimerix, Inc., ArtusLabs, and Liquidia Technologies. (more…)

November 14, 2011

13th Annual SEBIO Investor Forum a Huge Success

Filed under: SEBIO News — admin @ 6:34 pm

ATLANTA, GA - Nearly 400 people attended Southeast BIO’s (SEBIO) Thirteenth Annual Investor Forum, the region’s premier life sciences conference, held on November 2-3, 2011. Venture capitalists and angel investors connected with executives, life science entrepreneurs, university representatives and industry professionals in Durham, North Carolina to discuss opportunities for growth of the life sciences industry in the coming years.

“SEBIO continues to be the forum that draws all of the key members of the Southeast’s life science ecosystem: investors, entrepreneurs, technology transfer professionals and the life science business community come together in support of companies from across the Southeast,” said Aaron Davidson, Managing Director of H.I.G. Capital, Co-Head of H.I.G. BioVentures and newly elected Chair of SEBIO. “The Investor Forum provides a very efficient opportunity for the emerging leaders of tomorrow’s biopharmaceutical, medical technology and diagnostic companies to network with the other leaders of our ecosystem.”

Fred Eshelman, Founder and Executive Chairman of PPD, kicked off the two-day “Data Driven Deals” event by sharing highlights of his 20 year voyage of taking PPD from a one person start-up to the $3.9 billion buyout offer.

Jim Mullen, CEO of Patheon, closed the conference by offering his insights on how today’s pressures on the big pharma business model will impact cost structures in the future. The attendees were given a treat when North Carolina State Treasurer Janet Cowell unveiled the $35 million “Accelerator” investment fund, targeted for life sciences start-ups, at the event’s closing luncheon.

Twenty-eight of the most promising life sciences companies in the Southeast presented their funding pitches to representatives of more than 30 venture funds from across the U.S. The more advanced companies who have completed at least one round of institutional financing presented on the SEBIO MAIN/Stage. Twenty of the companies, as participants in the EARLY/Stage program or BIO/Plan Competition, were the beneficiaries of expert mentoring from teams made up of active venture capitalists and angel investors, entrepreneurs and managers, and service providers with relevant start-up expertise.

The EARLY/Stage program, geared for the best new initial investment opportunities in the region, allowed participants to introduce their companies to and seek advice from onsite advisory teams, who then chose the four best to participate in the EARLY/Stage Company Shootout on November 2. The selected participants were Arbovax, Inc. (Raleigh, NC), Claro Scientific, LLC (St. Petersburg, FL), Clinical Sensors, Inc. (Chapel Hill, NC) and NellOne Therapeutics, Inc. (Oak Ridge, TN).

Claro Scientific, LLC was selected as the winner of the EARLY/Stage Shootout by a panel of celebrity judges representing four venture capital funds. Claro Scientific is developing a portable, low cost, real time point of care diagnostic system for medical and research applications. The members of the Claro Scientific management team include Thomas McLain, CEO, and Luis Garcia-Rubio, President and CSO.

SEBIO also announced the winner of its fifth annual BIO/Plan Competition, which brings forward some of the most promising new technologies from the region’s research organizations. Four final competitors (CureSwitch, LLC, University of Florida; Infusense, LLC, University of Tennessee Health Science Center; Transcatheter Valve Technologies, Emory University; and ViaMune, Inc., University of Georgia) were selected from ten semifinalists who underwent a rigorous mentoring process over the past four months to develop an executable business strategy and associated written development plan.

The winner of the 2011 BIO/Plan Competition is Transcatheter Valve Technologies (TVT), a project developed at Emory University in Atlanta, Georgia. TVT is a percutaneous mitral valve replacement technology. The principals associated with TVT include Muralidhar Padala, Inventor, and James Greene, Industry Consultant.

The winning TVT mentoring team includes Bob Crutchfield, Harbert Venture Partners, John Perchorowicz, Triage Masters, and Harold Shlevin, Enterprise Innovation Institute at Georgia Tech.

The 2012 Southeast BIO Investor Forum will be held October 31 – November 1, 2012 at the Breakers Resort in Palm Beach, Florida. Further details will be posted on the SEBIO website (

September 28, 2011

24 Top Young Southeastern Life Science Firms to Strut Their Stuff at Investor Forum

Filed under: SEBIO News — admin @ 1:03 pm

ATLANTA, GA - Creative new drug therapies, advanced medical devices, diagnostics and nanotechnologies from throughout the Southeast will be in the spotlight November 2 and 3 during the 2011 Southeast BIO Investor Forum at the Washington Duke Inn in Durham, N.C.

July 26, 2011

Ten Semifinalists Selected in SEBIO’s Fifth Annual BIO/Plan Competition

Filed under: SEBIO News — admin @ 3:15 pm

Atlanta, GA -Southeast BIO announced that it has selected ten semifinalists in its fifth annual BIO/Plan Competition. Established to promote the creation of new life science companies and the development of exceptional corporate partnering opportunities in the Southeast U.S., the BIO/Plan Competition targets technology transfer offices and entrepreneurs throughout the region to bring forward opportunities from leading Southeastern research universities and centers.


April 30, 2011

Southeast BIO Venture Wire

Filed under: SEBIO News — admin @ 8:42 pm

ATLANTA, GA - The first quarter of 2011 was relatively strong for venture capital investment in the life sciences sector. According to the new MoneyTreeTM Report from PricewaterhouseCoopers LLP, dollars invested rose 16 percent to $1.4 billion, although deal volume fell by 9 percent. Overall, the life sciences sector tracked the larger venture capital market, in which much of the funding was directed to later stage deals with average deal size continuing to increase. (more…)

November 23, 2010

SEBIO Announces Winners of Annual Awards in Ceremony to Honor Top Regional Deals of the Year

Filed under: SEBIO News — admin @ 1:33 pm

Southeast BIO (SEBIO) announced the winners of the Fourth Annual SEBIO Awards in a ceremony held at its Twelfth Annual Investor Forum in Atlanta, Georgia on November 4th. The awards honored companies in the following categories: Southeast (SE) Deal of the Year: Initial Funding; SE Deal of the Year: Venture Capital Transaction, and SE Deal of the Year: Strategic Transaction. In addition, the organization awarded its SE Leadership Award to an individual or organization that made a notable contribution to the growth of the life sciences industry in the region over the last year. The winners were InVasc Therapeutics, Inc., TearScience, Inc., Alimera Sciences, Inc., and David Day of the University of Florida, respectively. (more…)

November 19, 2010

SEBIO Announces Success of 12th Annual Investor Forum; Winners of EARLY/Stage Shootout and BIO/Plan Competition Named

Filed under: SEBIO News — admin @ 4:44 pm

Southeast BIO’s (SEBIO) Twelfth Annual Investor Forum exuded an air of optimism for emerging life sciences companies in the Southeast region as executives from established enterprises told their recent financing, partnering, and exit success stories to nearly 350 attendees. The Investor Forum took place on November 3-4th in Atlanta, Georgia. (more…)

July 21, 2010

Ten Semifinalists Selected in SEBIO’s Fourth Annual BIO/Plan Competition

Filed under: SEBIO News — admin @ 2:05 pm

Atlanta, GA - Southeast BIO (SEBIO) announced that it has selected ten semifinalists in its fourth annual BIO/Plan Competition. Launched in 2007, the BIO/Plan Competition is a program developed to promote the creation of new life science companies based in the Southeast. (more…)

June 18, 2010

Form 8942 Released: Patient Protection and Affordable Care Act Tax Credit and Grant for Qualifying Therapeutic Discovery Projects

Filed under: SEBIO News — admin @ 4:34 pm

Washington, DC - Today the IRS released Form 8942, the application to receive a tax credit or grant for qualifying therapeutic discovery projects. (more…)

December 22, 2009

SEBIO Announces Restorative Physiology Group as the Grand Prize Winner in the Third Annual BIO/Plan Competition

Filed under: SEBIO News — admin @ 11:37 am

Atlanta, GA - Southeast BIO (SEBIO) has announced the winner of its third annual BIO/Plan Competition, a year-long business creation competition. The winner is Restorative Physiology Group, LLC (Charleston, SC). Restorative Physiology Group will take home the BIO/Plan grand prize valued at $100,000.00 in non-dilutive cash and services. (more…)

Next Page »